Julie Cooke Neurocrine Biosciences Inc (NBIX) insider trading activity

Julie Cooke is Chief Human Resources Officer of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 20,190 shares of NBIX, which is worth approximately $2.4 Million. The most recent transaction as insider was on Feb 13, 2025, when has been sold 1,551 shares (Common Stock) at a price of $116.79 per share, resulting in proceeds of $181,141. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.2K

10.92% 3M change

12.32% 12M change

Total Value Held $2.4 Million

Julie Cooke Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 13 2025	SELL Open market or private sale	$181,141 $116.79 p/Share	1,551 Reduced 7.13%	20,190 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	2,910 Added 12.2%	20,945 Common Stock
Feb 10 2025	SELL Open market or private sale	$82,796 $118.28 p/Share	700 Reduced 3.58%	18,831 Common Stock
Feb 08 2025	BUY Exercise of conversion of derivative security	-	1,329 Added 6.37%	19,531 Common Stock
Jan 31 2025	SELL Open market or private sale	$266,028 $152.89 p/Share	1,740 Reduced 8.73%	18,202 Common Stock
Jan 31 2025	BUY Exercise of conversion of derivative security	-	1,740 Added 8.03%	19,942 Common Stock
Aug 01 2024	SELL Open market or private sale	$1,935,980 $153.26 p/Share	12,632 Reduced 40.97%	18,202 Common Stock
Aug 01 2024	BUY Exercise of conversion of derivative security	$780,910 $61.82 p/Share	12,632 Added 29.06%	30,834 Common Stock
Jul 16 2024	SELL Open market or private sale	$135,036 $150.04 p/Share	900 Reduced 4.71%	18,202 Common Stock
Jul 16 2024	BUY Exercise of conversion of derivative security	$55,638 $61.82 p/Share	900 Added 4.5%	19,102 Common Stock
Jul 01 2024	SELL Open market or private sale	$1,401,900 $140.19 p/Share	10,000 Reduced 35.46%	18,202 Common Stock
Jul 01 2024	BUY Exercise of conversion of derivative security	$618,200 $61.82 p/Share	10,000 Added 26.18%	28,202 Common Stock
Feb 13 2024	SELL Open market or private sale	$105,899 $133.04 p/Share	796 Reduced 4.24%	17,976 Common Stock
Feb 08 2024	SELL Open market or private sale	$180,079 $135.5 p/Share	1,329 Reduced 7.15%	17,263 Common Stock
Feb 06 2024	SELL Open market or private sale	$172,615 $142.07 p/Share	1,215 Reduced 6.58%	17,263 Common Stock
Jan 31 2024	SELL Open market or private sale	$245,896 $141.32 p/Share	1,740 Reduced 9.16%	17,263 Common Stock
Dec 22 2023	SELL Open market or private sale	$3,081,359 $128.39 p/Share	24,000 Reduced 58.16%	17,263 Common Stock
Dec 22 2023	BUY Exercise of conversion of derivative security	$1,714,560 $71.44 p/Share	24,000 Added 46.82%	27,263 Common Stock
Sep 01 2023	SELL Open market or private sale	$91,406 $110.93 p/Share	824 Reduced 4.56%	17,263 Common Stock
Aug 21 2023	SELL Open market or private sale	$228,998 $107.41 p/Share	2,132 Reduced 10.54%	18,087 Common Stock
May 01 2023	SELL Open market or private sale	$1,184,034 $103.89 p/Share	11,397 Reduced 41.34%	16,169 Common Stock
Apr 25 2023	SELL Open market or private sale	$10,382 $103.82 p/Share	100 Reduced 0.36%	27,561 Common Stock
Feb 08 2023	SELL Open market or private sale	$137,872 $103.82 p/Share	1,328 Reduced 4.62%	27,424 Common Stock
Feb 07 2023	SELL Open market or private sale	$1,495,754 $102.9 p/Share	14,536 Reduced 34.64%	27,424 Common Stock
Feb 06 2023	SELL Open market or private sale	$127,429 $104.88 p/Share	1,215 Reduced 7.09%	15,926 Common Stock

Julie Cooke

Chief Human Resources Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBIX shares.

Notify only if

Value

Insider Trading

Get notified when an Neurocrine Biosciences Inc insider buys or sells NBIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to NEUROCRINE BIOSCIENCES INC

Track Activities on NBIX

Account